Xoma reported $134.96M in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 15.72M 18.72M
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Celldex Therapeutics CLDX:US $ 398.1M 21.38M
Chimerix CMRX:US $ 47.8M 20.45M
Curis CRIS:US $ 62.04M 13.93M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Emergent Biosolutions EBS:US $ 1513.2M 62.1M
Epizyme EPZM:US $ 11.12M 31.81M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
Life Technologies LIFE:US $ 98.55M 10.75M
Macrogenics MGNX:US $ 178.21M 61.4M
Novartis NOVN:VX SF 62925M 1385M
Novartis NVS:US $ 62925M 1385M
Prothena PRTA:US $ 438.89M 27.16M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Teva Pharmaceutical Industries TEVA:US $ 9037M 307M
Xoma XOMA:US $ 134.96M 4.97M
YTE INCY:US $ 4085.06M 221.99M